Figure S2 page1 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer

<p>Figure S2 page1</p>

Enregistré dans:

Détails bibliographiques
Auteur principal:	Craig M. Goodwin (14955973) (author)
Autres auteurs:	Andrew M. Waters (14953065) (author), Jennifer E. Klomp (14961282) (author), Sehrish Javaid (14961285) (author), Kirsten L. Bryant (14955976) (author), Clint A. Stalnecker (14955952) (author), Kristina Drizyte-Miller (14961288) (author), Bjoern Papke (14961291) (author), Runying Yang (14961294) (author), Amber M. Amparo (14961297) (author), Irem Ozkan-Dagliyan (14961300) (author), Elisa Baldelli (14961303) (author), Valerie Calvert (14961306) (author), Mariaelena Pierobon (14961309) (author), Jessica A. Sorrentino (14961312) (author), Andrew P. Beelen (14961315) (author), Natalie Bublitz (14961318) (author), Mareen Lüthen (14961321) (author), Kris C. Wood (14961324) (author), Emanuel F. Petricoin (14961327) (author), Christine Sers (12163648) (author), Autumn J. McRee (14961330) (author), Adrienne D. Cox (14953077) (author), Channing J. Der (14961333) (author)
Publié:	2025
Sujets:	Cancer Cancer Biology Molecular and Cellular Biology Cell Cycle CDKs and CDK inhibitors Cell Signaling Guanine nucleotide binding proteins and effectors DNA Damage and Repair DNA damage Oncogenes & Tumor Suppressors Kras Oncogenes Rb and family
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires